Gift an article

Why isn't SA getting these life-saving TB drugs?

Share your Subscriber Article
You have 5 articles to share every month. Send this story to a friend!
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
loading...
Loading, please wait...
Photo: © Bruno De Cock. Source: http://www.msf.org/
Photo: © Bruno De Cock. Source: http://www.msf.org/

Doctors Without Borders (MSF) and other treatment providers in South Africa and globally have found that the first new drugs in half a century to be developed for treating drug-resistant tuberculosis (DR-TB) are offering new hope to patients — but significant challenges remain to improve availability and affordability of these treatments.

Current treatment regimens for DR-TB involve thousands of pills taken over two years, which can have devastating side effects and ultimately only work for 50% of people with multidrug-resistant (MDR) TB and 26% of people with extensively drug-resistant (XDR) TB.

Read: Research into TB and HIV unveils hope and challenges

Read this for free
Get 14 days free to read all our investigative and in-depth journalism. Thereafter you will be billed R75 per month. You can cancel anytime and if you cancel within 14 days you won't be billed.
Try FREE for 14 days
Already a subscriber? Sign in
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE